Filing Details

Accession Number:
0001209191-11-059540
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-12-05 17:55:09
Reporting Period:
2011-12-01
Filing Date:
2011-12-05
Accepted Time:
2011-12-05 17:55:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1459450 Myrexis Inc. MYRX Pharmaceutical Preparations (2834) 263996918
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1376960 Jason Aryeh C/O Myrexis, Inc.
305 Chipeta Way
Salt Lake City UT 84108
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-12-01 42,618 $2.65 402,644 No 4 P Indirect By JALAA Equities, LP
Common Stock Acquisiton 2011-12-02 27,600 $2.69 430,244 No 4 P Indirect By JALAA Equities, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By JALAA Equities, LP
No 4 P Indirect By JALAA Equities, LP
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 9,900 Indirect By Trust
Footnotes
  1. The shares were purchased in multiple transactions at prices ranging from $2.64 to $2.67 per share. The price reported above is the weighted average purchase price. See footnote (4)
  2. The Reporting Person is the founder and general partner of JALAA Equities, LP.
  3. The shares were purchased in multiple transactions at prices ranging from $2.69 to $2.71 per share. The price reported above is the weighted average purchase price. See footnote (4)
  4. The Reporting Person hereby undertakes to provide upon request to the staff of the SEC, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth above.